Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered ...

We have developed a new, multidimensional diagnostic schema for COPD that incorporates spirometry, symptoms, and imaging and ...

CHRONOS 研究首次为 COPD 前驱期或早期阶段的干预提供了临床证据，证实了三联疗法在改善小气道功能和症状方面的有效性，为 COPD 的早期治疗开辟了新路径。同时，哮喘治疗向精准化、个体化方向的转变，也为哮喘患者的管理提供了更科学的策略。这些研究成果不仅丰富了呼吸系统疾病的治疗理论，更有望通过早期干预和精准治疗显著改善患者的生活质量，降低疾病负担，对推动呼吸医学领域的发展具有重要意义。

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year ...

The schema newly classified 15.4% of persons without airflow obstruction as having COPD by minor diagnostic category, Surya P ...

Including imaging and symptom-based data in COPD diagnosis captures patients with high-risk disease otherwise overlooked.

Eucalyptus oil might be at or near the top of the essential oils list for these patients, given its storied history in both ...

2025 — Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive pulmonary disease (COPD ...